Cancer BiologybioRxiv
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators
O. Castellanet, F. Ahmad, Y. Vinik…·F. Maina
This study shows that blocking BCL-XL makes TNBC cells vulnerable to CDK1/2/4 inhibitors, but not other cell cycle regulators, through synergistic effects on survival and apoptosis pathways.